Clover Health Investments, Corp CLOV
Analyst Ratings
- Consensus
- Moderate Buy — 2 Buy · 2 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $4.88 (+27.5% upside)
Key Stats
- Today's Range
- $3.75 – $3.96
- 50-Day Range
- $3.75 – $5.28
- 52-Week Range
- $1.58 – $5.59
- Volume
- 3.86 million shs
- Average Volume
- 4.64 million shs
- Market Cap
- $2.02 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 2.07%
- Days to Cover
- 1.00
About Clover Health Investments, Corp
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Related Stocks
Compare head-to-head: CLOV vs UNH·CLOV vs CI·CLOV vs HUM·CLOV vs MOH
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
